专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明专利

FR2102503A5 未知
公开(公告)号：FR2102503A5
公开(公告)日：1972-04-07
申请号：FR7028992
申请日：1970-08-06
申请人： SAITO MASAHIRO
IPC分类号： F01C1/073 , F02B53/00 , F01C1/00 , F02B55/00

2. 发明专利

DE2039411A1 未知
公开(公告)号：DE2039411A1
公开(公告)日：1972-02-10
申请号：DE2039411
申请日：1970-08-07
申请人： SAITO MASAHIRO
发明人： SAITO MASAHIRO
IPC分类号： F01C1/073 , F02B53/00

3. 发明申请

WO1998029404A1 BENZOPYRAN DERIVATIVE ORIGINATING IN PROPOLIS 审中-公开
标题翻译： BENZOPYRAN DORIVATIVE ORIGINTING IN PROPOLIS
公开(公告)号：WO1998029404A1
公开(公告)日：1998-07-09
申请号：PCT/JP1996003860
申请日：1996-12-27
申请人： EIKEN KAGAKU KABUSHIKI KAISHA , MATSUNO, Tetsuya , MATSUMOTO, Yasuyuki , MORIKAWA, Junji , SAITO, Masahiro
发明人： EIKEN KAGAKU KABUSHIKI KAISHA
IPC分类号： C07D311/58
CPC分类号： C07D311/58
摘要： 3-[2-Dimethyl-8-(3-methyl-2-butenyl)benzopyran]-6-propenoic acid represented by chemical formula (I) and antitumor agents containing this compound and its salts as the active ingredient.
摘要翻译：由化学式（I）表示的3- [2-二甲基-8-（3-甲基-2-丁烯基）苯并吡喃] -6-丙烯酸和含有该化合物及其盐作为活性成分的抗肿瘤剂。

4. 发明申请

WO1996005877A1 METHOD OF STERILIZING PREFILLED SYRINGE MEDICINES 审中-公开
标题翻译：灭菌注射液药物灭菌方法
公开(公告)号：WO1996005877A1
公开(公告)日：1996-02-29
申请号：PCT/JP1995001644
申请日：1995-08-21
申请人： EIKEN CHEMICAL CO., LTD. , MATSUMOTO, Yasuyuki , SAITO, Masahiro , MORIKAWA, Junji , TAKANO, Hiroshi
发明人： EIKEN CHEMICAL CO., LTD.
IPC分类号： A61M05/31
CPC分类号： A61L2/06 , A61L2/26 , A61M5/001
摘要： The invention provides a method of sterilizing a chemical and an injector in a prefilled syringe and keeping them in sterilized condition, said method comprising mounting a liquid leakage preventive cap (1) on a tip end of an injector (2) in a prefilled syringe, filled with a chemical and mounting a sliding plug (3) in an opening at a rear end of the injector to prevent liquid leakage of the prefilled syringe, securing the prefilled syringe, which mounts thereto the liquid leakage preventive cap (1) and the sliding plug (3), by means of a securing container (6), sealing the securing container (6), to which the prefilled syringe (2) is fixed, by means of a poromeric and bacteria impermeable nonwoven paper or fabric to sterilize a chemical (5) in the prefilled syringe (2), the prefilled syringe (2) and the securing container at the same time. The securing container (6) is enclosed by a bag-shaped nonwoven paper or fabric (7). Alternatively, the securing container (6) may have an opening, and the opening may be sealed by the nonwoven paper or fabric (11). According to the invention, it is possible to manufacture a prefilled syringe kit readily at low cost in a sterilized manner and keep the sterilized condition.
摘要翻译：本发明提供了一种在预充式注射器中对化学药剂和注射器进行灭菌并将其保持在灭菌状态的方法，所述方法包括将防漏液帽（1）安装在预充式注射器中的注射器（2）的末端上，填充有化学品并将滑动塞（3）安装在喷射器后端的开口中，以防止预填充的注射器的液体泄漏，固定预充式注射器，该注射器安装在防漏液盖（1）上并滑动通过固定容器（6）将塞子（3），借助于通孔和细菌不可渗透的非织造纸或织物将固定的预充式注射器（2）固定到其上的固定容器（6）进行灭菌（5）在预充式注射器（2）中，预充式注射器（2）和固定容器同时进行。固定容器（6）由袋状非织造纸或织物（7）包围。或者，固定容器（6）可以具有开口，并且开口可以被非织造纸或织物（11）密封。根据本发明，可以以无菌方式以低成本容易地制造预填充注射器套件并保持灭菌状态。

5. 发明申请

WO2009020236A2 NOVEL VIRAL VECTOR 审中-公开
标题翻译：新的VIRAL VECTOR
公开(公告)号：WO2009020236A2
公开(公告)日：2009-02-12
申请号：PCT/JP2008/064503
申请日：2008-08-06
申请人： EDUCATIONAL FOUNDATION JICHI MEDICAL UNIVERSITY , OTSUKA PHARMACEUTICAL CO., LTD. , YOSHIDA, Shigeto , KAWASAKI, Masanori , MATSUMOTO, Makoto , OHBA, Yoshio , SAITO, Masahiro , GOTO, Yoshihiro , INAGAKI, Katsuya , MIZUKOSHI, Masami , HARIGUCHI, Norimitsu , HIROTA, Kuniko
发明人： YOSHIDA, Shigeto , KAWASAKI, Masanori , MATSUMOTO, Makoto , OHBA, Yoshio , SAITO, Masahiro , GOTO, Yoshihiro , INAGAKI, Katsuya , MIZUKOSHI, Masami , HARIGUCHI, Norimitsu , HIROTA, Kuniko
IPC分类号： C12N15/866 , A61K39/145 , A61K39/015
CPC分类号： C07K16/1018 , A61K39/015 , A61K39/12 , A61K39/145 , A61K2039/5256 , C07K14/005 , C07K14/445 , C07K16/205 , C07K2319/735 , C12N7/00 , C12N15/86 , C12N2710/14122 , C12N2710/14143 , C12N2760/16122 , C12N2760/16134 , C12N2830/15 , C12N2830/60 , C12N2830/85 , Y02A50/412
摘要： The present invention provides a novel transfer vector and a recombinant baculovirus; methods for the production thereof; and pharmaceuticals containing the recombinant baculovirus as an active ingredient, which are useful as preventive or therapeutic drugs for infectious diseases such as malaria and influenza. More specifically, the invention provides a recombinant transfer vector capable of expressing a foreign gene fused to a virus gene under the control of a dual promoter; a recombinant baculovirus; methods for the production thereof; and pharmaceuticals containing the recombinant baculovirus as an active ingredient.
摘要翻译：本发明提供新型转移载体和重组杆状病毒; 生产方法; 以及含有重组杆状病毒作为活性成分的药物，其可用作疟疾和流感等感染性疾病的预防或治疗药物。更具体地，本发明提供能够表达在双重启动子控制下与病毒基因融合的外源基因的重组转移载体; 重组杆状病毒; 生产方法; 以及含有重组杆状病毒作为有效成分的药物。

6. 发明申请

WO1997024115A1 NAPHTHALENECARBOXYLIC ACID DERIVATIVES 审中-公开
标题翻译：萘二甲酸衍生物
公开(公告)号：WO1997024115A1
公开(公告)日：1997-07-10
申请号：PCT/JP1996003859
申请日：1996-12-27
申请人： EIKEN KAGAKU KABUSHIKI KAISHA , MATSUNO, Tetsuya , MATSUMOTO, Yasuyuki , MORIKAWA, Junji , SAITO, Masahiro
发明人： EIKEN KAGAKU KABUSHIKI KAISHA
IPC分类号： A61K31/19
CPC分类号： A61K31/19
摘要： Antitumor agents containing as the active ingredient 1,2,3,4,4a,7,8,8a-octahydro-1,4a,5-trimethyl-1-(3-methyl-5-oxo-3-pentenyl)-2-naphthalenecarboxylic acids represented by chemical formula (I) or isomers or salts thereof.
摘要翻译：含有作为活性成分的1,2,3,4,4a，7,8,8a-八氢-1,4a，5-三甲基-1-（3-甲基-5-氧代-3-戊烯基）-2 由化学式（I）表示的萘甲酸或其异构体或其盐。

7. 发明申请

WO1997003070A1 NOVEL BENZIMIDAZOLE DERIVATIVES HAVING CGMP-PHOSPHODISTERASE INHIBITING ACTIVITY 审中-公开
标题翻译：具有CGMP-磷酸二酯酶抑制活性的新型苯并咪唑衍生物
公开(公告)号：WO1997003070A1
公开(公告)日：1997-01-30
申请号：PCT/JP1996001841
申请日：1996-07-03
申请人： OTSUKA PHARMACEUTICAL CO., LTD. , NISHI, Takao , SATO, Seiji , NAGATANI, Takeshi , YUKAWA, Hirotaka , KOGA, Nobuyuki , SAITO, Masahiro , YOSHINAGA, Shinji
发明人： OTSUKA PHARMACEUTICAL CO., LTD.
IPC分类号： C07D403/12
CPC分类号： C07D231/12 , C07D233/56 , C07D249/08 , C07D401/12 , C07D401/14 , C07D403/12 , C07D403/14 , C07D413/12 , C07D413/14
摘要： The present invention provides novel benzimidazole derivatives or salts thereof represented by general formula (1), wherein R is a hydrogen atom or a halogen atom; R is a phenyl-lower alkyl group; R is a heterocyclic group selected from the group consisting of an indolyl group, indolinyl group, 1H-indazolyl group, 2(1H)-quinolinonyl group, 3,4-dihydro-2(1H)-quinolinonyl group and 1,4-benzoxazinyl group; A is a lower alkylene group; n is 0 or 1. The benzimidazole derivatives or salts of the present invention are effective agents for treating various arteriosclerotic diseases.
摘要翻译：本发明提供由通式（1）表示的新的苯并咪唑衍生物或其盐，其中R 1是氢原子或卤素原子; R 2是苯基 - 低级烷基; R 3是选自吲哚基，二氢吲哚基，1H-吲唑基，2（1H） - 喹啉酮基，3,4-二氢-2（1H） - 喹啉酮基和1， 4-苯并恶嗪基; A A是低级亚烷基; 本发明的苯并咪唑衍生物或其盐是治疗各种动脉硬化性疾病的有效药物。

8. 发明申请

WO2009020236A3 BACULOVIRAL VECTORS WITH A DUAL VERTEBRATE AND BACULOVIRUS PROMOTER CONTROLLING AN IMMUNOGENIC FUSION GENE 审中-公开
标题翻译：具有双重VERTEBRATE和BACULVVUSUS PROMOTER控制免疫原性融合基因的BACULOVIRAL VECTORS
公开(公告)号：WO2009020236A3
公开(公告)日：2009-04-16
申请号：PCT/JP2008064503
申请日：2008-08-06
申请人： EDUCATIONAL FOUNDATION JICHI M , OTSUKA PHARMA CO LTD , YOSHIDA SHIGETO , KAWASAKI MASANORI , MATSUMOTO MAKOTO , OHBA YOSHIO , SAITO MASAHIRO , GOTO YOSHIHIRO , INAGAKI KATSUYA , MIZUKOSHI MASAMI , HARIGUCHI NORIMITSU , HIROTA KUNIKO
发明人： YOSHIDA SHIGETO , KAWASAKI MASANORI , MATSUMOTO MAKOTO , OHBA YOSHIO , SAITO MASAHIRO , GOTO YOSHIHIRO , INAGAKI KATSUYA , MIZUKOSHI MASAMI , HARIGUCHI NORIMITSU , HIROTA KUNIKO
IPC分类号： C12N15/866 , A61K39/015 , A61K39/145
CPC分类号： C07K16/1018 , A61K39/015 , A61K39/12 , A61K39/145 , A61K2039/5256 , C07K14/005 , C07K14/445 , C07K16/205 , C07K2319/735 , C12N7/00 , C12N15/86 , C12N2710/14122 , C12N2710/14143 , C12N2760/16122 , C12N2760/16134 , C12N2830/15 , C12N2830/60 , C12N2830/85
摘要： The present invention provides a novel transfer vector and a recombinant baculovirus; methods for the production thereof; and pharmaceuticals containing the recombinant baculovirus as an active ingredient, which are useful as preventive or therapeutic drugs for infectious diseases such as malaria and influenza. More specifically, the invention provides a recombinant transfer vector capable of expressing a foreign gene fused to a virus gene under the control of a dual promoter; a recombinant baculovirus; methods for the production thereof; and pharmaceuticals containing the recombinant baculovirus as an active ingredient.
摘要翻译：本发明提供新型转移载体和重组杆状病毒; 生产方法; 以及含有重组杆状病毒作为活性成分的药物，其可用作疟疾和流感等感染性疾病的预防或治疗药物。更具体地，本发明提供能够表达在双重启动子控制下与病毒基因融合的外源基因的重组转移载体; 重组杆状病毒; 生产方法; 以及含有重组杆状病毒作为有效成分的药物。

9. 发明专利

JPH07303719A NOVEL SPORTS FOR MAKING NOVEL SPORTS AS TOYS 失效
公开(公告)号：JPH07303719A
公开(公告)日：1995-11-21
申请号：JP5800394
申请日：1994-02-17
申请人： SAITO MASAHIRO
发明人： SAITO MASAHIRO
IPC分类号： A63B67/00 , A63F13/812
摘要： PURPOSE:To make ball games as powerful sports by increasing the patterns of the tricks thereof. CONSTITUTION:Rule defines a player not to walk >=2 steps by carrying a ball. The player is allowed to dribble the ball with his feet or hands when he walks. The coat is formed smaller than that for soccer and larger than that for handballs. The same holds true of goals. The coat is covered with walls. The game is continued even if the ball is hit against the walls or against the wire nets thereon but the opponent team which lets the ball out of the wire nets is given a free throw or shoot in case the ball is let out of the wire nets. The next play may be started as it is without shooting the ball and in such a case the ball must be thrown backward.

10. 发明专利

JP2000288395A CATALYST FOR DEHYDROGENATION OF CYCLOHEXANOL 失效
公开(公告)号：JP2000288395A
公开(公告)日：2000-10-17
申请号：JP10067799
申请日：1999-04-07
申请人： AGENCY IND SCIENCE TECHN , SAITO MASAHIRO , SUDE CHEMIE NISSAN CATALYSTS I
发明人： SAITO MASAHIRO , KITAMURA TADAKUNI , SUGATA MORIYASU
IPC分类号： B01J23/80 , C07B61/00 , C07C45/29 , C07C49/403
摘要： PROBLEM TO BE SOLVED: To enable a high catalytic activity to be maintained for a long time in the dehydrogenation of cyclohexanol by forming a catalyst for the dehydrogenation of cyclohexanol of copper oxide, zinc oxide and magnesium aluminate. SOLUTION: The catalyst for the dehydrogenation of cyclohexanol is composed of copper oxide, zinc oxide and magnesium aluminate. When the gross weight of the catalyst is given as 100 wt.%, the ratio of the copper oxide, zinc oxide and magnesium aluminate is set to be 20-60 wt.%, 30-70 wt.% and 0.1-10 wt.% respectively. When these components are set at the ratio other than described, the degree of the dehydrogenation activity of the cyclohexanol and the stability of the activity over time are insufficient. The catalyst is manufactured by producing a precursor sediment and cleaning/drying it and further baking it. Further, a water-soluble salt such as a nitrate or a sulfate can be used as a raw material for copper, zinc, magnesium or aluminum which are the components of the catalyst.

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式